Perinatal mental health refers to mental health during pregnancy and up to one year postpartum. Perinatal mood and anxiety disorders (PMADs) are the most common complication of childbirth — affecting approximately 1 in 5 mothers and 1 in 10 fathers/non-birthing partners. Despite their prevalence, they are frequently unscreened, underdiagnosed, and undertreated.
Baby blues — tearfulness, mood swings, anxiety, and emotional lability in the first 2 weeks postpartum — affect 80% of new parents and resolve on their own as hormones stabilize. Postpartum depression is distinguished by: persistence beyond 2 weeks, greater severity, significant impairment in functioning, and symptoms that don't naturally resolve. PPD is not "hormones" — it's a treatable clinical condition requiring professional attention.
PMADs include more than PPD: Postpartum anxiety (often more prevalent than PPD) — persistent worry, racing thoughts, physical tension, difficulty sleeping even when the baby sleeps. Postpartum OCD — intrusive thoughts, often disturbing and ego-dystonic, about harm coming to the baby; these thoughts are not dangerous and do not mean a parent will act on them. Postpartum PTSD — following a traumatic birth experience. Postpartum psychosis — rare (0.1-0.2%), requires emergency psychiatric care; symptoms include hallucinations, delusions, rapid mood shifts, confusion.
Postpartum Support International (postpartum.net) maintains the most comprehensive perinatal provider directory in the United States, with search by specialty and location. PSI also offers free peer support phone calls (1-800-944-4773) from volunteer parents who have recovered from PMADs. Provider training and certification in perinatal mental health is offered through PSI and the Postpartum Health Alliance.
CBT and Interpersonal Therapy (IPT) adapted for the perinatal period are first-line treatments. Brexanolone (Zulresso) — a neurosteroid — and zuranolone (Zurzuvae) are FDA-approved specifically for postpartum depression and work rapidly (within days). SSRIs and SNRIs are also used and are compatible with breastfeeding in most cases. A perinatal psychiatrist can advise on medication safety during breastfeeding.